Willingness to return to enrolling institution for follow up
102.0
Willingness to return to enrolling institution for follow-up during the active monitoring phase (that is, the active treatment and observation portion) of the study); patients who have been formally transferred to another active and approved site participating in this study would not need to return to the enrolling institution for this purpose
360.0
Willing to return to Alliance enrolling institution for follow-up
48.0
Willing to return to enrolling medical site for all study assessments
1120.0
Willing to return to enrolling institution for follow-up during the Active Monitoring Phase (the active treatment and observation portions) of the study; patients are encouraged to return to the enrolling institution; however, patients may receive radiation therapy at a different institution other than the enrolling institution
265.0
Willing to return to an Alliance enrolling institution for follow-up
224.0
Willing to return to enrolling institution for follow-up (during the Active Monitoring Phase of the study)
330.0
Willingness to return to the enrolling institution for follow-up
45.0
